The board approved a $2.5 billion increase to the existing $2.0 billion share repurchase authorization, leaving approximately $3.1 billion available under the program. The program has no expiration date and may be terminated by the board at any time.
MKL · Markel Group Inc.
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Key stats
- Short volume, last session
- 29%
- Last earnings
- Oct 29, 2026
- Latest filing
- 10-Q · Oct 28
- Price history
- Jan 2020 to Nov 2026
Up next
Latest documents
Markel Group reported adjusted operating income of $707 million, up 14%, and secured $1.2 billion of adverse development protection while funding $315 million in share repurchases.
Markel Group's insurance subsidiaries agreed to an Adverse Development Cover Agreement with Cavello Bay Reinsurance Limited, a wholly owned subsidiary of Enstar Group Limited, covering run-off business with net reserves of $4.8 billion. The reinsurance premium is $2.4 billion, paid through a transfer of assets at closing, and the Reinsurer covers 100% of covered losses above an aggregate retention of $2.6 billion. Closing is subject to regulatory approval and is expected by the end of the fourth quarter of 2026.
On October 27, 2026, Markel Insurance entered into an adverse development cover reinsurance agreement with Cavello Bay Reinsurance Limited, a subsidiary of Enstar Group Limited, covering $4.8 billion of subject reserves. Markel Insurance will retain the first $2.6 billion of reserves and pay a $120 million risk premium.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Net investment gains | -$280.91M | FY2026 Q3 | -164.9% |
|
|
|||
| additional gross written premiums for these coverages | $34.5M | the second quarter of 2026 filing | — |
| Adjusted operating income (loss) - Financial non-GAAP | -148.94M | Quarter Ended June 30, 2026 filing | — |
| Adjusted operating income - Industrial non-GAAP | 75.43M | Quarter Ended June 30, 2026 filing | — |
| adjusted underwriting gross premium volume non-GAAP | 10% | quarter ended June 30, 2026 filing | — |
| Ceded losses and loss adjustment expenses | -621.13M | Quarter Ended June 30, 2026 filing | — |
| Change in fair value of equity securities | $1.17B | Quarter Ended June 30, 2026 filing | — |
| Combined ratio - International | 82% | Quarter Ended June 30, 2026 filing | — |
| Combined ratio - Markel Insurance | 92.9% | Quarter Ended June 30, 2026 filing | — |
| Combined ratio - Programs and Solutions | 94.2% | Quarter Ended June 30, 2026 filing | — |
| Combined ratio - U.S. Wholesale and Specialty | 97.1% | Quarter Ended June 30, 2026 filing | — |
| Combined ratio, excluding current accident year catastrophe impact (1) non-GAAP | 90.8% | quarter ended June 30, 2026 filing | — |
| Consolidated earned premiums - Assumed | 820.67M | Quarter Ended June 30, 2026 filing | — |
| Consolidated earned premiums - Ceded | -1.81B | Quarter Ended June 30, 2026 filing | — |
| Consolidated earned premiums - Direct | 3.06B | Quarter Ended June 30, 2026 filing | — |
| Consolidated earned premiums - Net Premiums | 2.07B | Quarter Ended June 30, 2026 filing | — |
| Consolidated written premiums - Assumed | 1.15B | Quarter Ended June 30, 2026 filing | — |
| Consolidated written premiums - Ceded | -2.45B | Quarter Ended June 30, 2026 filing | — |
| Consolidated written premiums - Direct | 3.42B | Quarter Ended June 30, 2026 filing | — |
| Consolidated written premiums - Net Premiums | 2.12B | Quarter Ended June 30, 2026 filing | — |
| Consolidated: Assumed earned premiums to net earned premiums | 40% | Quarter Ended June 30, 2026 filing | — |
| Consolidated: Ceded earned premiums to gross earned premiums | 47% | Quarter Ended June 30, 2026 filing | — |
| Corporate adjusted operating income non-GAAP | $22.28M | Quarter Ended June 30, 2026 filing | — |
| Corporate and eliminations adjusted operating income non-GAAP | $10.99M | Quarter Ended June 30, 2026 filing | — |
| Current accident year loss ratio | 65.5% | quarter ended June 30, 2026 filing | — |
| Current accident year loss ratio catastrophe impact (4) | 2.1% | quarter ended June 30, 2026 filing | — |
| Current accident year loss ratio, excluding catastrophe impact (1) non-GAAP | 63.4% | quarter ended June 30, 2026 filing | — |
| Earned premiums - Markel Insurance | 1.99B | Quarter Ended June 30, 2026 filing | — |
| Expense ratio | 35.7% | quarter ended June 30, 2026 filing | — |
| Expense ratio - Global Reinsurance | 26.6% | Quarter Ended June 30, 2026 filing | — |
| Expense ratio - International | 40.4% | Quarter Ended June 30, 2026 filing | — |
| Expense ratio - Markel Insurance | 35.7% | Quarter Ended June 30, 2026 filing | — |
| Expense ratio - Programs and Solutions | 36.6% | Quarter Ended June 30, 2026 filing | — |
| Expense ratio - U.S. Wholesale and Specialty | 31.9% | Quarter Ended June 30, 2026 filing | — |
| favorable development on prior accident years loss reserves | 166.6M | quarter ended June 30, 2026 filing | — |
| Fronting | 1.28B | quarter ended June 30, 2026 filing | — |
| Fronting earned premiums - Assumed | 504.2M | Quarter Ended June 30, 2026 filing | — |
| Fronting earned premiums - Ceded | -1.36B | Quarter Ended June 30, 2026 filing | — |
| Fronting earned premiums - Direct | 853.49M | Quarter Ended June 30, 2026 filing | — |
| Fronting earned premiums - Net Premiums | -2K | Quarter Ended June 30, 2026 filing | — |
| fronting gross premium volume attributable to Global Reinsurance | 154.1M | quarter ended June 30, 2026 filing | — |
| fronting gross premium volume attributable to Nephila | 783.1M | quarter ended June 30, 2026 filing | — |
| fronting gross premium volume attributed to Hagerty | 344.8M | quarter ended June 30, 2026 filing | — |
| Fronting written premiums - Assumed | 969.79M | Quarter Ended June 30, 2026 filing | — |
| Fronting written premiums - Ceded | -2.11B | Quarter Ended June 30, 2026 filing | — |
| Fronting written premiums - Direct | 1.14B | Quarter Ended June 30, 2026 filing | — |
| Fronting written premiums - Net Premiums | 5K | Quarter Ended June 30, 2026 filing | — |
| Global Reinsurance division combined ratio | 124% | quarter ended June 30, 2026 filing | — |
| Gross losses and loss adjustment expenses | 1.81B | Quarter Ended June 30, 2026 filing | — |
| Gross losses related to fronted premiums | 993.5M | quarter ended June 30, 2026 filing | — |
| Gross premium volume - Markel Insurance | 3.67B | Quarter Ended June 30, 2026 filing | — |
| Gross premiums written through Nephila programs | 769.4M | quarter ended June 30, 2026 filing | — |
| Gross written premiums attributable to Hagerty | 344.84M | the quarter ended June 30, 2026 filing | — |
| gross written premiums from the Nephila Reinsurers under this fronting program | $15.5M | the quarter ended June 30, 2026 filing | — |
| Less: Global Reinsurance division underwriting gross premium volume | -$15.23M | Quarter Ended June 30, 2026 filing | — |
| Loss ratio | 57.1% | quarter ended June 30, 2026 filing | — |
| Loss ratio - Global Reinsurance | 97% | Quarter Ended June 30, 2026 filing | — |
| Loss ratio - International | 41.6% | Quarter Ended June 30, 2026 filing | — |
| Loss ratio - Markel Insurance | 57.1% | Quarter Ended June 30, 2026 filing | — |
| Loss ratio - Programs and Solutions | 57.6% | Quarter Ended June 30, 2026 filing | — |
| Loss ratio - U.S. Wholesale and Specialty | 65.2% | Quarter Ended June 30, 2026 filing | — |
| Net investment income | $256.12M | Quarter Ended June 30, 2026 filing | — |
| Net losses and loss adjustment expenses | 1.19B | Quarter Ended June 30, 2026 filing | — |
| net losses and loss adjustment expenses related to the Middle East conflict | $41M | the quarter ended June 30, 2026 filing | — |
| Net realized investment losses | -$2.93M | Quarter Ended June 30, 2026 filing | — |
| Net retention of underwriting gross premium volume | 86% | quarter ended June 30, 2026 filing | — |
| Net written premiums | 2.04B | quarter ended June 30, 2026 filing | — |
| Organic revenue growth - Financial non-GAAP | 3% | the quarter ended June 30, 2026 filing | — |
| Premiums ceded to Hagerty Re | 330.19M | the quarter ended June 30, 2026 filing | — |
| Prior accident years loss ratio | -8.4% | quarter ended June 30, 2026 filing | — |
| Prior accident years loss ratio - Global Reinsurance | 4.9% | Quarter Ended June 30, 2026 filing | — |
| Prior accident years loss ratio - International | -13.4% | Quarter Ended June 30, 2026 filing | — |
| Prior accident years loss ratio - Markel Insurance | -8.4% | Quarter Ended June 30, 2026 filing | — |
| Prior accident years loss ratio - Programs and Solutions | -12.9% | Quarter Ended June 30, 2026 filing | — |
| Prior accident years loss ratio - U.S. Wholesale and Specialty | -1.4% | Quarter Ended June 30, 2026 filing | — |
| Return on equity securities (2) | 9.9% | Quarter Ended June 30, 2026 filing | — |
| Revenue growth | 4% | quarter ended June 30, 2026 filing | — |
| total fund management revenues attributed to unconsolidated entities managed by Nephila | $37.7M | the quarter ended June 30, 2026 filing | — |
| Underwriting | 2.39B | quarter ended June 30, 2026 filing | — |
| Underwriting earned premiums - Assumed | 316.47M | Quarter Ended June 30, 2026 filing | — |
| Underwriting earned premiums - Ceded | -453.7M | Quarter Ended June 30, 2026 filing | — |
| Underwriting earned premiums - Direct | 2.21B | Quarter Ended June 30, 2026 filing | — |
| Underwriting earned premiums - Net Premiums | 2.07B | Quarter Ended June 30, 2026 filing | — |
| Underwriting profit | $148.82M | Quarter Ended June 30, 2026 filing | — |
| Underwriting profit (loss) - Markel Insurance | 142.12M | Quarter Ended June 30, 2026 filing | — |
| Underwriting written premiums - Assumed | 184.14M | Quarter Ended June 30, 2026 filing | — |
| Underwriting written premiums - Ceded | -343.42M | Quarter Ended June 30, 2026 filing | — |
| Underwriting written premiums - Direct | 2.28B | Quarter Ended June 30, 2026 filing | — |
| Underwriting written premiums - Net Premiums | 2.12B | Quarter Ended June 30, 2026 filing | — |
| Underwriting: Assumed earned premiums to net earned premiums | 15% | Quarter Ended June 30, 2026 filing | — |
| Underwriting: Ceded earned premiums to gross earned premiums | 18% | Quarter Ended June 30, 2026 filing | — |
| Yield on cash and cash equivalents and restricted cash and cash equivalents (1) | 2.8% | Quarter Ended June 30, 2026 filing | — |
| Yield on fixed maturity securities (1) | 3.7% | Quarter Ended June 30, 2026 filing | — |
| Yield on short-term investments (1) | 3.3% | Quarter Ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance - Property & Casualty — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MKL
this stock
Markel Group Inc.
|
$23.68B | -9.9% | +4.7% | 13.2 | 2.1% |
|
CB
Chubb Ltd
|
$141.99B | +19.1% | +6.5% | 13.0 | 0.8% |
|
PGR
Progressive Corp
|
$134.06B | +1.6% | +16.3% | 11.7 | 1.3% |
|
TKOMY
Tokio Marine Holdings, Inc.
|
$102.34B | — | — | — | 0.0% |
|
TRV
Travelers Companies, Inc.
|
$80.59B | +35.6% | +5.2% | 10.3 | 2.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Amount
- $100.0K–$250.0K
- Traded
- Aug 25, 2026
- Filed
- Nov 18, 2026
- This year
- 16
The board approved a $2.5 billion increase to the existing $2.0 billion share repurchase authorization, leaving approximately $3.1 billion available under the program. The program has no expiration date and may be terminated by the board at any time.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MKL | -2.1% | +3.6% | +8.3% | +3.6% | -9.9% |
| SPY | -8.6% | -9.2% | -9.2% | -8.7% | +1.2% |
| vs SPY | +6.5% | +12.8% | +17.5% | +12.3% | -11.1% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.